Highlights
- Ramsay Health Care shares jumped 4.6% to AU$35.81, their highest level since December 2023.
- The company forecasts 1H25 underlying NPAT of AU$150M–AU$160M, exceeding analyst expectations.
- Ramsay flagged a AU$305M impairment for its UK segment but noted an improved hospital valuation.
Ramsay Health Care Ltd (ASX:RHC) saw its shares climb 4.6% on Monday, reaching AU$35.81—the highest level since December 18, 2023. The surge follows the company’s upbeat earnings forecast for the first half of FY25, which surpassed market expectations.
Stronger-Than-Expected Profit Guidance
Ramsay expects its underlying net profit after tax (NPAT) for 1H25 to be between AU$150 million and AU$160 million. This outlook is significantly ahead of the Visible Alpha consensus estimate of AU$142.6 million and well above the AU$140.4 million reported in the same period last year.
The positive forecast indicates continued operational strength for the healthcare provider, which has been focusing on growth in both its Australian and international operations.
UK Segment Impairment and Valuation Adjustments
Despite the strong profit outlook, Ramsay flagged a AU$305 million goodwill and asset impairment in its UK segment, which will be reflected in its 1H25 accounts. The impairment is a result of revised financial projections for its UK operations, but the company highlighted that the valuation of Ramsay UK Hospitals has increased.
This suggests that while short-term accounting adjustments may impact financial statements, the long-term outlook for its UK assets remains positive.
Stock Performance and Market Reaction
Ramsay Health Care’s stock had been relatively flat for the year before Monday’s rally.